Adrenocortical Carcinoma
📧 Sign up to get email alerts when something new happens for Adrenocortical Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-18Clinical Trial Update: Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy [Phase 1, Phase 2]
The document reports completion of Phase 1 and Phase 2 evaluation of 123I-Iodometomidate for adrenal scintigraphy. It focuses on adrenal tum…
-
CLINICAL_TRIALS trial_result · 2009-02-24Clinical Trial Update: Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients [Phase 2]
A Phase 2 trial evaluating sorafenib in combination with paclitaxel for adrenocortical carcinoma, with the trial status listed as unknown.
-
FDA approval · 2009-02-10FDA Approved: LYSODREN — Supplemental Application (ESTEVE PHARMACEUTICALS, S.A.)
FDA approved a supplemental application for LYSODREN (mitotane) filed by ESTEVE PHARMACEUTICALS, S.A.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection [Phase 2]
Phase 2 clinical trial evaluating continuous infusion doxorubicin, vincristine and etoposide with daily mitotane administered before and aft…